HeartSciences Adds Key Advisor to its Scientific Advisory Board
February 26, 2024 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Expands its Scientific Advisory Board
February 12, 2024 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Appoints New Scientific Advisory Board Member
February 01, 2024 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
January 18, 2024 08:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting
January 03, 2024 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), would like to remind its shareholders to...
HeartSciences Reports Second Quarter Fiscal 2024 Financial Results
December 14, 2023 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway
December 05, 2023 08:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
November 20, 2023 08:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers
November 13, 2023 08:45 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology...
HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments
October 19, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Entered into Transformative Agreements with Icahn Mount Sinai Filed FDA Pre-Submission Request to Change to 510(k) Submission from De Novo following Issuance of New Classification for AI ECG by FDA...